Switch to: Citations

Add references

You must login to add references.
  1. Treatability Statements in Serious Illness: The Gap Between What is Said and What is Heard.Jason N. Batten, Bonnie O. Wong, William F. Hanks & David C. Magnus - 2019 - Cambridge Quarterly of Healthcare Ethics 28 (3):394-404.
    :Empirical work has shown that patients and physicians have markedly divergent understandings of treatability statements in the context of serious illness. Patients often understand treatability statements as conveying good news for prognosis and quality of life. In contrast, physicians often do not intend treatability statements to convey improvement in prognosis or quality of life, but merely that a treatment is available. Similarly, patients often understand treatability statements as conveying encouragement to hope and pursue further treatment, though this may not be (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception.K. P. Weinfurt, Daniel P. Sulmasy, Kevin A. Schulman & Neal J. Meropol - 2003 - Theoretical Medicine and Bioethics 24 (4):329-344.
    The ethical treatment of cancer patientsparticipating in clinical trials requiresthat patients are well-informed about thepotential benefits and risks associated withparticipation. When patients enrolled in phaseI clinical trials report that their chance ofbenefit is very high, this is often taken as evidence of a failure of the informed consent process. We argue, however, that some simple themes from the philosophy of language may make such a conclusion less certain. First, the patient may receive conflicting statements from multiple speakers about the expected (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations